Araceli Biosciences

United States Founded: 2020 • Age: 6 yrs
Scientific tools for tissue and cell-based biomarker discovery are developed.
Request Access

About Araceli Biosciences

Araceli Biosciences is a company based in United States founded in 2020.. Araceli Biosciences has raised $15.95 million across 3 funding rounds from investors including Bill Cortelyou. Araceli Biosciences offers products and services including Endeavor Automation and Clairvoyance Software. Araceli Biosciences operates in a competitive market with competitors including Lodestone Biomedical, BioImage, BioAmp Diagnostics, HAWK Biosystems and Genosaber, among others.

  • Headquarter United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $15.95 M (USD)

    in 3 rounds

  • Latest Funding Round
    $11.2 M (USD), Seed

    Apr 24, 2025

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Araceli Biosciences

Araceli Biosciences offers a comprehensive portfolio of products and services, including Endeavor Automation and Clairvoyance Software. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Hardware for rapid plate scanning in drug discovery processes

Software for advanced image analysis in therapeutic research

People of Araceli Biosciences
Headcount 10-50
Employee Profiles 18
Employee Profiles
People
Kevin Ferguson
Principal Systems Engineer
People
Timm Derrickson
Data Scientist–Software Engineer
People
Mike Bitsch
Principal Design Engineer
People
Bill Cortelyou
Chief Executive Officer

Unlock access to complete

Funding Insights of Araceli Biosciences

Araceli Biosciences has successfully raised a total of $15.95M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $11.2 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Seed — $11.2M
  • First Round

    (11 Apr 2023)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2025 Amount Seed - Araceli Biosciences Valuation Bill Cortelyou
Dec, 2024 Amount Seed - Araceli Biosciences Valuation

investors

Apr, 2023 Amount Seed - Araceli Biosciences Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Araceli Biosciences

Araceli Biosciences has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Bill Cortelyou. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Angel
Investor Description Founded Year Domain Location

Bill Cortelyou

-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Araceli Biosciences

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Araceli Biosciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Araceli Biosciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Araceli Biosciences

Araceli Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lodestone Biomedical, BioImage, BioAmp Diagnostics, HAWK Biosystems and Genosaber, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of magnetic nanoparticle platform technology for in vivo biomarker monitoring in immuno-oncology
domain founded_year HQ Location
Bioassays are developed for biopharmaceutical firms and research organizations.
domain founded_year HQ Location
Developers of diagnostic tests that help to treat patient with a specific antibiotic
domain founded_year HQ Location
Clinical assays are developed for quantifying novel biomarkers in samples.
domain founded_year HQ Location
Diagnostic tools for detecting circulating tumor cells are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Araceli Biosciences

Frequently Asked Questions about Araceli Biosciences

When was Araceli Biosciences founded?

Araceli Biosciences was founded in 2020 and raised its 1st funding round 3 years after it was founded.

Where is Araceli Biosciences located?

Araceli Biosciences is headquartered in United States.

Is Araceli Biosciences a funded company?

Araceli Biosciences is a funded company, having raised a total of $15.95M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2.23M, raised on Apr 11, 2023.

What does Araceli Biosciences do?

Developer of scientific tools for tissue and cell-based biomarker discovery drug development. The company is involved in the development of an instrumentation system to improve precision analysis of products by using artificial intelligence. It has developed an endeavor molecular imaging device that helps to identify cell counting, cell cycle, cell differentiation, cell morphology, cell viability, and many more.

Who are the top competitors of Araceli Biosciences?

Araceli Biosciences's top competitors include Lodestone Biomedical, BioAmp Diagnostics and BioImage.

What products or services does Araceli Biosciences offer?

Araceli Biosciences offers Endeavor Automation and Clairvoyance Software.

Who are Araceli Biosciences's investors?

Araceli Biosciences has 1 investor. Key investors include Bill Cortelyou.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available